Survival rate from randomisation to 6 months was better in the breathlessness support service group than in the control group ( 50 of 53 [ 94 % ] vs 39 of 52 [ 75 % ] ) and in overall survival ( generalised Wilcoxon 390 , p = 0048 ) .